Colgate-Palmolive (NYSE:CL) Now Covered by Piper Sandler

Piper Sandler started coverage on shares of Colgate-Palmolive (NYSE:CL) in a report published on Tuesday, Marketbeat reports. The firm issued an overweight rating and a $121.00 price objective on the stock.

Other analysts have also recently issued reports about the stock. Wells Fargo & Company cut shares of Colgate-Palmolive from an equal weight rating to an underweight rating and set a $100.00 price target for the company. in a report on Monday, September 16th. HSBC reaffirmed a hold rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Stifel Nicolaus boosted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a buy rating in a research report on Monday, July 22nd. Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a buy rating in a research report on Wednesday, July 10th. Finally, Barclays boosted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an equal weight rating in a research report on Monday, July 29th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of Moderate Buy and a consensus target price of $104.74.

Colgate-Palmolive Trading Up 0.6 %

NYSE CL opened at $103.65 on Tuesday. The firm’s 50 day moving average price is $103.14 and its two-hundred day moving average price is $96.21. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $109.30. The stock has a market cap of $85.04 billion, a price-to-earnings ratio of 32.79, a PEG ratio of 3.62 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.77 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by insiders.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently bought and sold shares of the stock. Sanctuary Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $8,904,000. KPP Advisory Services LLC raised its stake in shares of Colgate-Palmolive by 6.3% in the 2nd quarter. KPP Advisory Services LLC now owns 8,899 shares of the company’s stock valued at $864,000 after buying an additional 525 shares in the last quarter. Ariadne Wealth Management LP acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $1,474,000. 3Chopt Investment Partners LLC acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $400,000. Finally, SPC Financial Inc. acquired a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $227,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.